收藏切换
Research on Japan's innovative drug R&D incentive policy and its enlightenment to China——an empirical study based on Takeda Pharmaceutical Company
收藏切换
Jian-zhou YAN, Jia-wen ZHU, Yan-yun CHEN, Jia-yuan LIU
Chinese Journal of New Drugs | 2021, 30(13) : 1153 - 1159
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(13): 1153-1159
Research on Japan's innovative drug R&D incentive policy and its enlightenment to China——an empirical study based on Takeda Pharmaceutical Company
Full
Jian-zhou YAN, Jia-wen ZHU, Yan-yun CHEN, Jia-yuan LIU
Affiliations
  • National Drug Policy and Medical Industry Economy Research Center, China Pharmaceutical University, Nanjing 211198, China
Published: 2021-07-15
Outline
收藏切换

The purpose of this paper is to provide reference for improving the incentive policies of innovative drug research and development in China. Taking Takeda Pharmaceutical Co., Ltd. as an empirical research object, and on the basis of combing Japan's innovative drug R&D incentive policies in terms of R&D support, registration review and approval, intellectual property rights and drug pricing, this paper analyzes how relevant policies encourage enterprises to innovate and develop from the aspects of mechanism and implementation effect. The results show that Takeda Pharmaceutical has achieved innovation transformation under a series of supports of innovative drug research and development incentive policies in Japan. In order to improve the related incentive policy in China, our country should learn from Japan's experience and take incentive measures, such as enhancing the commercial development of scientific research achievements, perfecting the intellectual property financing system, establishing and perfecting the drug data protection system and perfecting the price formation mechanism of innovative drugs.

Japan  /  innovation incentive  /  policy environment  /  Takeda Pharmaceuticals
颜建周, 朱佳文, 陈燕芸, 刘佳源. 日本创新药物研发激励政策研究及对我国的启示——基于武田制药公司的实证研究. 中国新药杂志, 2021 , 30 (13) : 1153 -1159 .
Jian-zhou YAN, Jia-wen ZHU, Yan-yun CHEN, Jia-yuan LIU. Research on Japan's innovative drug R&D incentive policy and its enlightenment to China——an empirical study based on Takeda Pharmaceutical Company[J]. Chinese Journal of New Drugs, 2021 , 30 (13) : 1153 -1159 .
Year 2021 volume 30 Issue 13
27
3
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-30
  • Published:2021-07-15
Article Data
Affiliations
History
  • Accepted:2021-01-12
Funding
Affiliations
    National Drug Policy and Medical Industry Economy Research Center, China Pharmaceutical University, Nanjing 211198, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT